PND HomeRFP BulletinJob CornerPND ArchivesFC Home

return to front page

Headlines

OMB Watch Posts Recommendations for Strengthening Nonprofit Sector

Aspen Institute Releases Statement on Nonprofit Advocacy Role

Robin Hood Foundation Honors Heroes in Fight Against Poverty

More Dot-Commers Seeking Nonprofit Jobs

Falling Stock Market Begins to Affect Charities

Cause-Related Marketing Catches on During Holiday Season

New Report Grades States on College Opportunities

World Health Organization and OSI Launch Health Network for Developing World

International Trachoma Initiative Expands Efforts

British University to Establish Research Center on Corporate Social Responsibility

    • • • • • •

Search

The Foundation Center

PHILANTHROPY NEWS DIGEST
   Vol. 6, Issue 50
   December 5, 2000

International Trachoma Initiative Expands Efforts

The New York City-based International Trachoma Initiative has announced that pilot projects in Morocco and Tanzania have cut the prevalence of the disease in those countries by well over 50 percent in just over a year.

A bacterial infection of the upper eyelid, trachoma has caused blindness in six million people worldwide, with another 150 million people currently infected.

"These results demonstrate that we are truly revolutionizing the control of this blinding disease," said ITI executive director Joseph Cook, M.D. The organization will report its results this week at the World Health Organization's Alliance for the Global Elimination of Trachoma by 2020 (GET 2020) conference.

The dramatic drop in the prevalence of the disease is largely due to the program's distribution of Pfizer Inc.'s antibiotic Zithromax on a massive scale in remote villages, as well as the initiative's support for an innovative health education strategy that emphasizes facial and community hygiene.

Based on its success in Morocco and Tanzania, the initiative will be expanded to reach 30 million people at risk of trachoma-related blindness worldwide. To support the program's expansion, Pfizer will donate approximately 10 million doses of Zithromax (valued at $14 per dose) and $6 million in funding for ITI's operating expenses over three years. Pfizer's partners in the efforts, the Edna McConnell Clark Foundation and the Bill & Melinda Gates Foundation, will also increase their funding, with the former contributing an additional $6 million over three years and the latter adding $20 million over five years.

"Anti-Blindness Campaign Cuts Disease Prevalence in Half Among Millions in Poorest Regions of Tanzania, Morocco." International Trachoma Initiative News Release 12/4/2000.

Ngowi, Rodrique. "Fight Against Forgotten Cause of Blindness Expands." Associated Press 12/5/2000.

FC003836


foundationcenter.org
© Foundation Center
All Rights Reserved.
Privacy Policy